Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.
From the official U.S. FDA label for BD Microfine Insulin Syringe, the active ingredient registered with NAFDAC.
INDICATIONS For the temporary relief of general weakness, debilitation, excessive sweating, or minor skin rash or hives due to sensitivity to phenolic compounds found in foods or other products.*
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
In case of overdose, get medical help or contact a poison control center right away. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
If pregnant or breastfeeding, ask a healthcare professional before use.
Add the expiry date on your pack for a full Trust Score.
BD Microfine Insulin Syringe contains Syringes (NA), as na, according to its NAFDAC registration record.
Yes. BD Microfine Insulin Syringe is listed on the NAFDAC register under registration number 03-6113, and its registration is active as of 27 October 2026.
No WHO falsified or substandard medical product alert currently matches BD Microfine Insulin Syringe in our automatically synced alert list.
Run a free authenticity scan with the NAFDAC number 03-6113, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.
INDICATIONS For the temporary relief of general weakness, debilitation, excessive sweating, or minor skin rash or hives due to sensitivity to phenolic compounds found in foods or other products.* (Summarised from the official U.S. FDA label for BD Microfine Insulin Syringe. Always follow your doctor or pharmacist.)
Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.